News 

SFS is acquiring Tegra Medical, a US company based in Franklin, Massachusetts. Tegra Medical is a leading development, production and contract manufacturing partner in the medical device market and generates sales of approx. USD 80 million with around 700 employees. This acquisition boosts SFS's penetration and customer base in the rapidly growing medical device market.

Tegra Medical develops and manufactures primarily disposable products made of metal and plastic for global, leading medical device OEMs. These products are used in orthopaedics, interventional therapies and minimally-invasive surgery. The product range includes surgical fasteners, stylets and cannulas, implants and instruments.

Tegra Medical will be integrated into the Engineered Components segment as an independent division. Tegra Medical's current executives will continue to manage the company. Upon completion of the transaction, Tegra Medical's current CEO J. Mark King will take a seat on the Group Executive Board of SFS Group and lead the "Medical" division.